#Puerto Rico #AI Technology #Carolina #CorePlus #Cervical Cytology

CorePlus Introduces Advanced Quality Control in Cervical Cytology

CorePlus, a pioneering organization in precision pathology based in Puerto Rico, has made headlines with a groundbreaking study that proposes a new era in cervical cytology. The study, recently published in the esteemed journal Cancer Cytopathology, emphasizes the integration of artificial intelligence (AI) and whole slide imaging (WSI) to achieve 100% quality control in cytology practices.

The New Face of Cytopathology

As the field of digital pathology evolves, laboratories like CorePlus are seeking alternatives to conventional manual microscopy. The study focuses on the Techcyte SureView™ system, which is meticulously tailored for digital cytopathology. CorePlus analyzed 1,442 digitized slides obtained from ThinPrep® and SurePath™ cervical cytology samples, pushing the boundaries of diagnostic excellence.

The slides were scanned using the state-of-the-art 3DHISTECH P1000 DX scanner, both under dry and water immersion conditions. A board-certified cytopathologist evaluated AI-identified anomalies, drawing contrasts between AI results and traditional light microscopy findings. The results were nothing short of impressive.

Impressive Performance Metrics

The SureView™ system showcased astounding results, significantly outpacing both dry scanning and manual microscopy in identifying squamous and glandular abnormalities. Key metrics from the research highlighted:

• - 97% Accuracy
• - 82% Sensitivity
• - 99% Specificity
• - 98% Negative Predictive Value
• - 86% Positive Predictive Value

In addition to its diagnostic prowess, the AI-driven technology markedly expedited review times, thereby enhancing overall workflow efficiency. This innovative approach signifies a paradigm shift in cervical cytology quality control, marking CorePlus as a leader in the application of digital and AI technologies in healthcare.

A Step Forward in Diagnostic Confidence

Following the study's validation, CorePlus has seamlessly implemented the Techcyte SureView™ system as an indispensable 100% quality control tool within its laboratory. This advancement not only elevates diagnostic accuracy but also enhances operational efficiencies, ultimately benefiting patient care.

Mariano de Socarraz, the founder and CEO of CorePlus, expressed his pride in this monumental achievement: "We have reached an unprecedented level of consistency and confidence in cervical cytology screening. Every PAP Counts! We are excited to participate in the progression of digital pathology and illustrate its tangible clinical impact."

Accessing the Comprehensive Study

To dive deeper into this pivotal research, interested parties can explore the complete study titled "Implementing 100% Quality Control in a Cervical Cytology Workflow Using Whole Slide Images and Artificial Intelligence" available at Wiley Online Library.

About CorePlus

CorePlus is dedicated to transforming the landscape of diagnostic services in Puerto Rico through innovative technology. The organization's commitment to enhancing patient outcomes through precise and effective diagnostic processes puts it at the forefront of precision pathology.

About Cancer Cytopathology

Cytopathology is a revered peer-reviewed medical journal sanctioned by the American Cancer Society, showcasing cutting-edge research and clinical studies designed to improve diagnostic accuracy and management in cancer care.

About Techcyte

Founded in 2013, Techcyte is revolutionizing pathology practices by digitizing laboratory workflows and facilitating AI-enhanced diagnostic testing. Their collaborative efforts with top-tier labs and technology vendors underscore their mission to make a positive impact on global health through innovation.

Conclusion

With CorePlus at the helm of this initiative, the convergence of AI and whole slide imaging technology marks an exciting chapter in cervical cytology, promising a future of enhanced accuracy, efficiency, and patient care.